Table 3.
Products | p-Value 1 | ||
---|---|---|---|
DP | Placebo | ||
ITT | |||
Change d0–d7 | −0.72 ± 3.25 | −0.62 ± 2.64 | 0.841 |
Change d0–d14 | −0.93 ± 2.84 | −0.41 ± 3.35 | 0.325 |
Change d0–d21 | −0.46 ± 3.05 | −0.36 ± 3.14 | 0.848 |
Time effect 2, p-value | 0.379 | 0.723 | |
Post-hoc analysis | >0.370 | 1.0 | |
PSQI d0 | 9.83 ± 2.90 | 9.91 ± 3.04 | 0.817 |
PSQI d7 | 9.24 ± 2.90 | 9.29 ± 3.43 | 0.863 |
PSQI d14 | 8.90 ± 2.61 | 9.51 ± 3.11 | 0.216 |
PSQI d21 | 9.36 ± 3.08 | 9.55 ± 3.02 | 0.717 |
Time effect 2, p-value | 0.072 | 0.389 | |
Post-hoc analysis | >0.068 | >0.321 | |
PP | |||
Change d0–d7 | −0.63 ± 3.32 | −0.55 ± 2.49 | 0.841 |
Change d0–d14 | −0.92 ± 2.93 | −0.22 ± 3.24 | 0.325 |
Change d0–d21 | −0.50 ± 3.01 | −020 ± 2.99 | 0.848 |
Time effect 2, p-value | 0.429 | 0.574 | |
Post-hoc analysis | >0.487 | >0.992 | |
PSQI d0 | 9.84 ± 3.00 | 9.89 ± 2.92 | 0.864 |
PSQI d7 | 9.37 ± 2.89 | 9.34 ± 3.38 | 0.920 |
PSQI d14 | 8.92 ± 2.67 | 9.67 ± 3.13 | 0.216 |
PSQI d21 | 9.34 ± 3.01 | 9.69 ± 3.06 | 0.717 |
Time effect 2, p-value | 0.101 | 0.511 | |
Post-hoc analysis | >0.117 | >0.501 | |
ModPP | |||
Change d0–d7 | −0.91 ± 3.10 | −066 ± 2.60 | 0.673 |
Change d0–d14 | −1.60 ± 2.53 | −0.30 ±3.28 | 0.034 |
Change d0–d21 | −1.17 ± 2.76 | 0.43 ± 3.17 | 0.227 |
Time effect 2, p-value | 0.228 | 0.682 | |
Post-hoc analysis | >0.448 | 1.0 | |
PSQI d0 | 10.85 ± 2.55 | 10.57 ± 2.68 | 0.609 |
PSQI d7 | 9.87 ± 2.97 | 9.91 ± 3.28 | 0.944 |
PSQI d14 | 9.26 ± 2.83 | 10.28 ± 2.85 | 0.085 |
PSQI d21 | 9.68 ± 3.07 | 10.15 ± 3.25 | 0.474 |
Time effect 2, p-value | 0.001 | 0.487 | |
Post-hoc analysis | 0–14 d: 0.001 0–21 d: 0.055 |
>0.531 |
Data are presented as mean ± SD. DP: dairy-based test product. Placebo: skimmed milk. ModPP: modified PP population. 1 Independent Samples Test. 2 One-way repeated measures ANOVA with Bonferroni post-hoc analysis.